CHU de Nice
Nice, France
Location status: Recruiting
Location contact
frederic Chorin, PhD
CONTACT
NCT Number: NCT06443138
Surgical management is one of the most frequently used interventions in the treatment of many cancers, but it can be associated with a high risk of postoperative complications.
The maintenance and optimization of functional abilities before, during and after treatment are major for elderly cancer patients, as it is now well established that there is a link between the level of functional capacity and the occurrence of these complications.
The scientific literature shows that the benefits of pre- and post-operative training programs, but these benefits only apply to a fraction of the patients adhering to the programs. The modalities of intervention (training load, follow-up, etc.) as well as patient involvement in these programs are major issues that need to be addressed to optimize their benefits.
Individualizing pre-habilitation, on the basis of the management of the training load, and therefore objective fatigue, would enable better patient adherence to the program, and optimize its benefits.
In this context, the PRIMECHO project aims to individualize pre-habilitation in order to improve functional of patients in the pre-habilitation or accelerated recovery after surgery phase. The aim is for the patient to be in optimum physical condition at the time of the intervention or treatment.
Interested in participating?
Request Info70 year and older
All sexes
Interventional
Not applicable
Nice, France
Location status: Recruiting
frederic Chorin, PhD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each patient will undergo 4 weeks of individualized pre-habilitation before surgery.
Each session (1 session per day) will be carried out autonomously by the patient at home, via a dedicated application (Activiti Pro) installed on their tablet or smartphone.
Time frame: at inclusion
Metres walked during 6 minutes
Time frame: at 4 weeks
Metres walked during the test
Time frame: at 8 weeks
Metres walked during the test
Time frame: at 16 weeks
Metres walked during the test
Time frame: at inclusion, 4 weeks, 8 weeks, 16 weeks
QLQC30 is a 30-item instrument designed to measure quality of life in all cancer patients.
It contains 30 questions and assesses the quality of life of oncological patients multidimensionally over 10 subscales. All sub-scales and the 6 individual items have a score range from 0 to 100 points. A higher score represents better function and a higher quality of life. In the symptom subscale, however, a higher score represents a higher level of symptoms or problems. Since there is no total score, all subscales and the individual items must be considered individually and evaluated using normative data.
Time frame: at inclusion, 4 weeks, 8 weeks, 16 weeks
Multidiensional Fatigue Inventory-20 (MFI-20) questionnaire. 5 scales. Higher scores means worse outcome.
General Fatigue dimension: Minimum value: 4. Maximum Value: 20. Physical fatigue dimension: Minimum value: 4. Maximum Value: 20. Reduced activity dimension: Minimum value: 4. Maximum Value: 20. Reduced motivation dimension: Minimum value: 4. Maximum Value: 20. Mental fatigue dimension: Minimum value: 4. Maximum Value: 20.
Time frame: at inclusion, 4 weeks, 8 weeks, 16 weeks
This questionnaire assesses overall physical activity and sedentary time over the last seven days. The questionnaire looks at intense, moderate and walking activity, as well as time spent sitting down (sedentary lifestyle), whether during leisure activities, at work, in daily life or during transport.
The questionnaire composed with 7 questions classifies the subject according to 3 levels of activity: inactive, moderate, high.
Contact information is provided by the study sponsor or research team.
Frédéric Chorin
CONTACT
Rabia Boulahssass, MD
CONTACT
Centre Hospitalier Universitaire de Nice
Other
Preparation for Medical and Surgical Procedures in Oncogeriatry. Pilote Study PRIMECHO
Acronym: PRIMECHO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07484932
Cancer (Solid Tumors), Geriatric Oncology
Hong Kong
View Trial DetailsNCT05710809
Atrophy, Balance Training
Copenhagen, Denmark
View Trial DetailsNCT07704307
Geriatric Oncology, Neoplasms
View Trial DetailsNCT07704073
Caregiver Quality of Life, Geriatric Medicine
Paris, France
View Trial Details